Sino Biopharmaceutical reported CNY2.59B in EBITDA for its fiscal semester ending in December of 2024.





Ebitda Change Date
Akebia Therapeutics USD 14.03M 17.19M Mar/2025
Alaunos Therapeutics USD -21.02M 1.33M Mar/2021
Avita Medical AUD -9.69M 12.21M Dec/2025
Cspc Pharmaceutical CNY 2.19B 21.88M Dec/2024
Dianthus Therapeutics USD -40.19M 5.36M Sep/2025
Ionis Pharmaceuticals USD -200.02M 42.89M Dec/2025
IQVIA Holdings USD 932M 114M Mar/2026
Jiangsu Hengrui CNY 2.3B 678.46M Dec/2025
Moderna USD -790M 582M Dec/2025
Organon & Co USD 415M 32M Mar/2026
Revvity USD 272.91M 24M Mar/2026
Sino Biopharmaceutical CNY 2.59B 1.57B Dec/2024
Tectonic Therapeutic USD -21.18M 365K Dec/2025
Viatris USD 1.05B 46.4M Mar/2026
Xeris Pharmaceuticals USD 25.09M 7.67M Dec/2025